Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention.

Literature DB >> 33184171

Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention.

Xiaoling Xu¹, Mingfeng Han², Tiantian Li³, Wei Sun², Dongsheng Wang³, Binqing Fu^4,5, Yonggang Zhou^4,5, Xiaohu Zheng^4,5, Yun Yang⁶, Xiuyong Li⁷, Xiaohua Zhang², Aijun Pan⁶, Haiming Wei^8,5.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2020 PMID： 33184171 PMCID： PMC7720178 DOI： 10.1073/pnas.2011616117

Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN： 0027-8424 Impact factor: 11.205

Keyword Cloud
References

× No keyword cloud information.

6 in total

1. Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19.

Authors: Savino Sciascia; Franco Aprà; Alessandra Baffa; Simone Baldovino; Daniela Boaro; Roberto Boero; Stefano Bonora; Andrea Calcagno; Irene Cecchi; Giacoma Cinnirella; Marcella Converso; Martina Cozzi; Paola Crosasso; Fabio De Iaco; Giovanni Di Perri; Mario Eandi; Roberta Fenoglio; Massimo Giusti; Daniele Imperiale; Gianlorenzo Imperiale; Sergio Livigni; Emilpaolo Manno; Carlo Massara; Valeria Milone; Giuseppe Natale; Mauro Navarra; Valentina Oddone; Sara Osella; Pavilio Piccioni; Massimo Radin; Dario Roccatello; Daniela Rossi
Journal: Clin Exp Rheumatol Date: 2020-05-01 Impact factor: 4.473

Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention.

1. Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19.

2. Safety concerns regarding concomitant use of tocilizumab and glucocorticoids in COVID-19 patients.

3. Tocilizumab treatment in COVID-19: A single center experience.

4. Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report.

5. Effective treatment of severe COVID-19 patients with tocilizumab.

6. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.